SCHEMBL428372

SCHEMBL428372

CC(O)CCCCCCO

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.43
TSHR P16473 3/20 0.43
ALDH1A1 P00352 3/20 0.43
HSD17B10 Q99714 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.42
TRPV1 Q8NER1 1/20 0.42
TRPA1 O75762 1/20 0.42
MAPT P10636 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PSMD14 O00487 2/20 0.36
PLA2G1B P04054 2/20 0.36
MMP2 P08253 2/20 0.36
ATG4B Q9Y4P1 2/20 0.36
HSP90AA1 P07900 1/20 0.36
RAD52 P43351 1/20 0.36
SPHK1 Q9NYA1 2/20 0.36
GMNN O75496 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8077217 1.00 LMNA (0.43) LMNATSHRALDH1A1HSD17B10MEN1
SCHEMBL830579 1.00 LMNA (0.43) LMNATSHRALDH1A1HSD17B10MEN1
SCHEMBL424124 1.00
SCHEMBL13202549 1.00 LMNA (0.43) LMNATSHRALDH1A1HSD17B10MEN1
SCHEMBL19411359 1.00 LMNA (0.43) LMNATSHRALDH1A1HSD17B10MEN1
1,6-Hexanediol SCHEMBL15347446 1.00 LMNA (0.43) LMNATSHRALDH1A1HSD17B10MEN1
SCHEMBL554360 1.00 LMNA (0.43) LMNATSHRALDH1A1HSD17B10MEN1
SCHEMBL10406986 1.00 LMNA (0.43) LMNATSHRALDH1A1HSD17B10MEN1
SCHEMBL5398466 1.00 LMNA (0.43) LMNATSHRALDH1A1HSD17B10MEN1
SCHEMBL12491774 1.00 LMNA (0.43) LMNATSHRALDH1A1HSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 543 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250040541-A1 AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2025-02-06 US claimed
EP-4451875-A1 AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP Investments LLC (US) 2024-10-30 EP claimed
CN-113631614-B Crystalline polyester polyol 汉高股份有限及两合公司 2024-03-15 CN claimed
CN-114933754-B High-resistance halogen-free flame-retardant cable sheath material and preparation method thereof 中瀚新材料科技有限公司 2023-12-29 CN claimed
CN-117050295-A Preparation method and application of polyalkylene ether glycol 上海沐深新材料科技有限公司 2023-11-14 CN claimed
EP-4257663-A1 FOOD CONTACT SURFACE SANITIZING LIQUID The Procter & Gamble Company (US) 2023-10-11 EP claimed
US-20230312451-A1 EFFICIENT DEPOLYMERIZATION METHOD OF POLYMERS COMPRISING ESTER FUNCTIONAL GROUP, AND PURIFICATION METHOD THEREOF KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2023-10-05 US claimed
WO-2023121411-A1 ECO-FRIENDLY METHOD FOR DECOLORIZATION AND DEPOLYMERIZATION OF COLORED POLYMER CONTAINING ESTER FUNCTIONAL GROUP 한국화학연구원 2023-06-29 WO claimed
WO-2023122003-A1 AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2023-06-29 WO claimed
US-20230147032-A1 PROCESS FOR PRODUCING POLYMER CAPACITORS FOR HIGH RELIABILITY APPLICATIONS HERAEUS EPURIO GMBH (DE) 2023-05-11 US claimed
US-20090197779-A1 METHOD FOR ENHANCED RECOVERY OF OIL FROM OIL RESERVOIRS E. I. DU PONT DE NEMOURS AND COMPANY 2009-08-06 US claimed
US-20090118465-A1 PREPARATION OF POLYTRIMTHYLENE ETHER GLYCOL OR COPOLYMERS THEREOF E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-05-07 US claimed
US-20090118464-A1 PREPARATION OF POLYTRIMETHYLENE ETHER GLYCOL OR COPOLYMERS THEREOF E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-05-07 US claimed
JP-2009517152-A 2009-04-30 JP claimed
EP-1956903-A1 USE OF A COMPOSITION COMPRISING PENTANE-1, 5-DIOL AS DEODORANT Ambria Dermatology AB (SE) 2008-08-20 EP claimed
WO-2007063065-A1 USE OF A COMPOSITION COMPRISING PENTANE-1, 5-DIOL AS DEODORANT AMBRIA DERMATOLOGY AB (SE) 2007-06-07 WO claimed
WO-2007062282-A2 A COATING COMPOSITION BASF CORPORATION (US) 2007-05-31 WO claimed
US-20070117955-A1 Coating composition BASF CORPORATION (US) 2007-05-24 US claimed
US-6899753-B2 Highly bleed-alleviating ink composition BENQ CORPORATION (TW) 2005-05-31 US claimed
US-20030037700-A1 Highly bleed-alleviating ink composition MIND FUSION, LLC 2003-02-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230312451-A1 EFFICIENT DEPOLYMERIZATION METHOD OF POLYMERS COMPRISING ESTER FUNCTIONAL GROUP, AND PURIFICATION METHOD THEREOF ALG1, TYR, ACP1 LMNA 774/4885TSHR 4437/4885ALDH1A1 737/4885
US-20250040541-A1 AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF RASGRP3, RSU1, RPP30 LMNA 2815/4885TSHR 4641/4885ALDH1A1 1445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.